Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
about
Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in SpainPopulation-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performanceThe evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutationsTrends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria.CLINICAL outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study.TB and HIV in the Central African region: current knowledge and knowledge gaps.Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaoundé, Cameroon.Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children.
P2860
Q28533216-0224D579-F2A4-4A4C-8AF9-7B6412FCBCA9Q28535652-DBA6ED65-61FB-4A19-A20C-D73AF8B68B23Q33570778-4B38AF26-8851-4B6D-A1ED-3CC39EE16F57Q35059630-63EF77DE-B91B-44A7-B871-98F0EBEDCA38Q35455456-880A65A4-2C0D-4E2E-8DF0-73B676757438Q37543203-A78876C5-8F36-4152-B76C-ECA0C5F535B1Q37726969-93896C1F-8679-4657-8B6E-3119D6D41B99Q38169113-F010AB76-B25F-48DA-ADBF-55FCB6BCC9A7Q38703935-8E17CE2B-0BA4-44B8-9D21-09B50D76DC6BQ42620819-108A0160-B2F1-4682-93E0-3DE3B52DEB23Q47138435-5AFB589E-EABB-4A4C-95B9-10AE782FFCF8Q55224546-2C148330-F718-44B1-924B-3AA69F67AC94
P2860
Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@en
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@nl
type
label
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@en
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@nl
prefLabel
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@en
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@nl
P2093
P2860
P50
P356
P1476
Characterization of drug resis ...... th HIV-1 in Yaounde, Cameroon.
@en
P2093
Aubin Nanfack
Desire Takou
Giulia Cappelli
Joseph Fokam
Judith Torimiro
Laura Ceccarelli
Sylvie Moudourou
Vittorio Colizzi
P2860
P304
P356
10.1002/JMV.23244
P577
2012-05-01T00:00:00Z